Sensex rises 25.63 points; capital goods, health care stocks up
A benchmark index of Indian equities markets was Thursday trading 25.63 points higher around 12:30 p.m., led by robust buying in capital goods, health care and FMCG stocks.
Stem Cell Technologies: World Market Outlook 2012-2022
NEW YORK, July 3, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Stem Cell Technologies: World Market Outlook 2012-2022 http://www.reportlinker.com/p0567594/Stem-Cell-Technologies-Worl…
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Antares Pharma, Inc. today announced the appointment of Jonathan S. Jaffe MD to the position of Vice President of Clinical Development. Jonathan’s background include
Do You Have These Stocks On Your Radar?
Do You Have These Stocks On Your Radar?
3SBio Gets SFDA Approval To Join Global Phase III Trial For Voclosporin
3SBio Gets SFDA Approval To Join Global Phase III Trial For Voclosporin
Alexion Sales Could Hit $1B; Who Gets The Jobs?
Imagine a disease in which a part of your immune system runs wild, destroying red blood cells and causing blood clots, strokes and, often, death within a few years. Now imagine a treatment that can curb that runaway process, saving the red blood cells …
Gazette.Net: Osiris scores approval down under for stem cell drug
Osiris Therapeutics has won a second nation’s imprimatur for its stem cell treatment for a deadly complication of bone marrow transplants in children.
InGen BioSciences Group, Exclusive Distributor for Cylex Incorporated in France, Reinforces its Translational Medicine …
CHILLY-MAZARIN, France, June 14, 2012 /PRNewswire/ –InGen BioSciences, specialised in the development and commercialisation of mono and multiparametric in vitro diagnostic tests announced a new exclusive …
Bio-Matrix' Regen BioPharma Unit Establishes Scientific Advisory Board and Research Relationship With Clinartis in …
SAN DIEGO, CA– -World renowned experts to accelerate development of stem cell therapeutics Regen anticipates new relationship with Clinartis to fast track clinical studies Bio-Matrix Scientific Group …
ViroPharma Initiates Phase II Study – Analyst Blog
ViroPharma Inc. ( VPHM ) recently announced the initiation of a phase II program. The phase II program will evaluate maribavir for the treatment of cytomegalovirus (CMV) infections in